Healthcare -
Biotechnology - NASDAQ - US
$ 493.756
-0.384 %
$ 52.4 B
Market Cap
12.27
P/E
REGN - COST OF REVENUE
Cost of Revenue REGN - Regeneron Pharmaceuticals, Inc.
1.97 B
LAST VALUE
12.38%
2 YEAR CAGR
20.30%
5 YEAR CAGR
25.39%
10 YEAR CAGR